Amsterdam-based Royal DSM has inked a deal to buy the Polymer Technology Group in Berkeley, CA, making it a world leader in polymers for biomedical research. The financial details were not disclosed, but PTG "expects to exceed USD $40 million in net sales with above-average operating profit margin."
"Through the acquisition of PTG, DSM Biomedical gains a leading global position in the fast-growing biomedical materials market," says Steve Hartig, president of DSM. "Our collective technology in combination with our expanded geographical and customer base will help us to develop a unique portfolio of products for the medical device industry. This will have immediate benefit to PTG's customers."
- check out the press release
Polymers show promise in lab-on-a-chip tech